• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 15, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Genetic study reveals similarities and differences of COVID-19 and SARS viruses

Bioengineer by Bioengineer
June 2, 2020
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Digital analysis finds potential structural differences in viral genetic code

IMAGE

Credit: First published in Wakida et al. 2020, DOI: 10.1016/j.bbrc.2020.05.008

Researchers have identified specific portions of the genetic codes of the COVID-19 and SARS viruses that may promote the viruses’ lifecycles. The new technique is researchers’ first tool for determining what genetic sequences stored as RNA – DNA’s chemical cousin – are more stable.

“The current pandemic is very severe, and we want to contribute to the global acceleration of coronavirus research. Our research includes many types of viruses, but we decided to focus on our coronavirus results,” said Professor Nobuyoshi Akimitsu, leader of the research team that performed the work and an expert in how cells withstand stress at the University of Tokyo Isotope Science Center.

Many families of viruses – including influenza viruses and coronaviruses – store their genetic sequence as RNA, which sneaks into human cells and tricks them into making more viruses. Viruses need their RNA to remain stable, resisting efforts from the host’s immune system to degrade their RNA.

The research team named their technique Fate-seq because it aims to determine the fate of a genetic sequence, whether it will persist or degrade based on its stability.

“The Fate-seq technique is a very simple idea. We combined existing technologies in a new way,” explained Akimitsu.

To perform Fate-seq, researchers first cut a genome into short fragments. Even extremely dangerous pathogens become harmless when researchers only work with short, separated, cut-up fragments of their genomes.

Researchers synthesized RNAs from the fragments of virus genomes and examined their fate, that is stability, by using next-generation sequencing, which allows researchers to quickly and simultaneously identify the exact sequence of individual strands of RNA. Computer programs can then identify patterns or interesting differences in the genetic sequences to study in further detail.

Researchers studied 11,848 RNA sequences from 26 virus genomes, including that of SARS-CoV, the virus that causes SARS, the sudden acute respiratory syndrome that killed 774 people in the first half of 2003. Researchers identified a total of 625 stable RNA fragments. Among the stable RNA fragments, 21 were from SARS-CoV.

Researchers compared the 21 SARS-CoV stable genome fragments to the full genetic sequence data available for other types of coronaviruses. Two of the stable fragments from the SARS-CoV are very common in other evolutionarily similar coronaviruses, including the virus that causes COVID-19, SARS-CoV-2.

Predictive models showed that those two stable RNA fragments likely form stem-and-loop structures. Stem-and-loops are short pieces of RNA that, instead of remaining a straight line, fold forward and bind onto themselves, forming a hairpin shape.

Most notably, one of the stable fragments only forms a stem-and-loop in the COVID-19 virus, not the SARS virus due to the few small but important differences in the viruses’ RNA codes.

“The stem-and-loop structure of this SARS-CoV-2 genetic fragment is very stable in computer models and we propose that this structure might enhance survival of the virus,” said Akimitsu.

In addition to better understanding dangerous viruses, researchers hope to use Fate-seq to understand the fundamental rules of RNA stability and advance new types of medicine. Human cells use RNA as the intermediate messenger between DNA and protein. Designing RNA-based drugs that are stable and easy for cells to translate into protein could treat genetic diseases without the hazards of altering our DNA.

###

This research was performed with collaborators at the University of Tsukuba and is a peer-reviewed publication in the journal Biochemical and Biophysical Research Communications.

Research Article

Hiroyasu Wakida, Kentaro Kawata, Yuta Yamaji, Emi Hattori, Takaho Tsuchiya, Youichiro Wada, Haruka Ozaki, Nobuyoshi Akimitsu. 6 May 2020. Stability of RNA sequences derived from the coronavirus genome in human cells. Biochemical and Biophysical Research Communications. DOI: 10.1016/j.bbrc.2020.05.008
https://doi.org/10.1016/j.bbrc.2020.05.008

Related Links

Akimitsu Lab: https://akimitsu.ric.u-tokyo.ac.jp/en/
Isotope Science Center (in Japanese): https://www.ric.u-tokyo.ac.jp/

Research contact

Professor Nobuyoshi Akimitsu

Isotope Science Center, The University of Tokyo

Tel: +81-(0)3-5841-3057

E-mail: [email protected]

Press officer contact

Ms. Caitlin Devor

Division for Strategic Public Relations, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku,

Tokyo 133-8654, JAPAN

Tel: +81-080-9707-8178

Email: [email protected]

About the University of Tokyo

The University of Tokyo is Japan’s leading university and one of the world’s top research universities. The vast research output of some 6,000 researchers is published in the world’s top journals across the arts and sciences. Our vibrant student body of around 15,000 undergraduate and 15,000 graduate students includes over 4,000 international students. Find out more at http://www.u-tokyo.ac.jp/en/ or follow us on Twitter at @UTokyo_News_en.

Media Contact
Professor Nobuyoshi Akimitsu
[email protected]

Related Journal Article

http://dx.doi.org/10.1016/j.bbrc.2020.05.008

Tags: BiologyEvolutionGenesGeneticsInfectious/Emerging DiseasesMedicine/HealthVirology
Share13Tweet8Share2ShareShareShare2

Related Posts

Innovative Technologies Poised to Enhance Care for Parkinson’s Patients

Innovative Technologies Poised to Enhance Care for Parkinson’s Patients

August 15, 2025
blank

Humanized ALK Antibody-Drug Shows Cancer-Fighting Promise

August 15, 2025

Advancing Precision Interventions and Metrics for Inflammaging

August 15, 2025

University of Oklahoma’s Smoking Cessation App Shows Strong Results in Clinical Trial

August 15, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Innovative Network Offers Promising Advances in Predicting Health Issues in Dogs

Innovative Technologies Poised to Enhance Care for Parkinson’s Patients

Ocular Side Effects Associated with Semaglutide: New Insights

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.